Switch to:
More From Other Websites
Hemispherx Biopharma Reaches Agreement with Avrio Biopharmaceuticals for the Accelerated Production... Jul 27 2016
8:34 am Hemispherx Biopharma reaches an agreement with Avrio Biopharmaceuticals to serve as an... Jul 27 2016
Hemispherx Biopharma Reaches Agreement with Avrio Biopharmaceuticals for the Accelerated Production... Jul 27 2016
Hemispherx Announces First Shipment of Rintatolimod (Ampligen®) to Early Access Program in Europe Jul 25 2016
Hemispherx Announces First Shipment of Rintatolimod (Ampligen®) to Early Access Program in Europe Jul 25 2016
Hemispherx Biopharma Bolsters Manufacturing and Scientific Capabilities Through Key Consulting and... Jul 19 2016
Hemispherx Outlines Key Elements of Strategic Growth Plan and Commitment to Transparency Jul 14 2016
Hemispherx Outlines Key Elements of Strategic Growth Plan and Commitment to Transparency Jul 14 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 11 2016
Hemispherx Updates the Status of the Alferon® Manufacturing Facility Jul 11 2016
Hemispherx Updates the Status of the Alferon® Manufacturing Facility Jul 11 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 20 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jun 10 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 08 2016
Hemispherx Biopharma Enters into Settlement Agreements Dismissing All Pending Shareholder Derivative... Jun 08 2016
Hemispherx gets IP rights from the CEO it fired Jun 07 2016
Hemispherx Biopharma: Dr. William M. Mitchell Publishes Article Titled, "Efficacy of Rintatolimod in... Jun 07 2016
Hemispherx Biopharma: Dr. William M. Mitchell Publishes Article Titled, “Efficacy of Rintatolimod... Jun 07 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events Jun 06 2016
Hemispherx Biopharma Obtains a Comprehensive Carter Omnibus Assignment of Intellectual Property Jun 06 2016
Hemispherx Biopharma Obtains a Comprehensive Carter Omnibus Assignment of Intellectual Property Jun 06 2016
Early Morning Technical Highlights on Biotech Stocks May 31 2016
Hemispherx Biopharma Renews Sales, Marketing, Distribution and Supply Agreement with GP Pharm May 31 2016
Hemispherx Biopharma Renews Sales, Marketing, Distribution and Supply Agreement with GP Pharm May 31 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events May 25 2016
HEMISPHERX BIOPHARMA INC Financials May 24 2016
UPDATE -- Hemispherx Amends and Restates Agreement with myTomorrows for the Early Access Program for... May 24 2016
Hemispherx Amends and Restates Agreement with myTomorrows for the Early Access Program for... May 23 2016
Hemispherx Amends and Restates Agreement with myTomorrows for the Early Access Program for... May 23 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 16 2016
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2016 May 16 2016
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2016 May 16 2016
Hemispherx Biopharma Announces Conference Call to Provide Quarterly Business Update on May 17, 2016 May 12 2016
Hemispherx Biopharma Retains Huron Consulting Group to Support Partnering Strategy and Planning for... Apr 20 2016
Hemispherx Biopharma Enters into Alfa-n3 Interferon Clinical Trial, Sales, Marketing, Distribution,... Apr 04 2016
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2015 Apr 01 2016
Hemispherx Biopharma Reviews Ampligen® Data with National Institute of Neurological Disorders and... Apr 01 2016
HEMISPHERX BIOPHARMA ANNOUNCES FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2015 Hemispherx... Mar 30 2016
Hemispherx Biopharma Announces Conference Call to Discuss Management Changes and Provide Corporate... Mar 22 2016
Hemispherx Biopharma Europe N.V./S.A. : Orphan Medicine Designation and European Medicines Agency... Jan 20 2016
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2015 …... Nov 17 2015
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion on Application for Orphan... Oct 19 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK